Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients

BACKGROUND: In a time of increasing concerns over personalized and precision treatment in breast cancer (BC), filtering prognostic factors attracts more attention. Apoptosis-Inducing Factor Mitochondrion-associated 3 (AIFM3) is widely expressed in various tissues and aberrantly expressed in several...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ang, Zhang, Lin, Song, Xinyue, Wang, Yuying, Wei, Minjie, Jin, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518782/
https://www.ncbi.nlm.nih.gov/pubmed/31088422
http://dx.doi.org/10.1186/s12885-019-5659-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518782/
https://www.ncbi.nlm.nih.gov/pubmed/31088422
http://dx.doi.org/10.1186/s12885-019-5659-4

Ejemplares similares